As of Feb 26, 2024, RayzeBio Inc. Common Stock has 69,419 shares failed to deliver, representing 9.31% of the average daily volume of 745,490 shares. Over the past year, the monthly average FTD is 33,393 shares, with the current level 108% above the historical average, indicating elevated settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.